Hosted on MSN
The rise of 'agonorexia': People are developing brand new eating disorders on GLP-1 agonist drugs
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...
When most people think about "healthy eating," they usually focus on what they eat. That might mean trying to eat more fruit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results